Trazodone, dibenzoylmethane and tauroursodeoxycholic acid do not prevent motor dysfunction and neurodegeneration in Marinesco-Sjögren syndrome mice

G Lavigna, A Grasso, C Pasini, V Grande, L Mignogna… - bioRxiv, 2024 - biorxiv.org
There is no cure for Marinesco-Sjögren syndrome (MSS), a genetic multisystem disease
linked to loss-of-function mutations in the SIL1 gene, encoding a BiP co-chaperone. We …

PERK inhibition delays neurodegeneration and improves motor function in a mouse model of Marinesco-Sjögren syndrome

V Grande, F Ornaghi, L Comerio… - Human molecular …, 2018 - academic.oup.com
Marinesco-Sjögren syndrome (MSS) is a rare, early onset, autosomal recessive multisystem
disorder characterized by cerebellar ataxia, cataracts and myopathy. Most MSS cases are …

Neuroprotective modulation of the unfolded protein response in Marinesco-Sjögren syndrome: PERK signaling inhibition and beyond

E Restelli, A Masone, M Sallese… - Neural Regeneration …, 2019 - journals.lww.com
Individuals with Marinesco-Sjögren syndrome (MSS; OMIM 248800), a genetic disease of
infancy, suffer various disabilities, including loss of motor coordination due to cerebellar …

[HTML][HTML] PERK inhibition attenuates the abnormalities of the secretory pathway and the increased apoptotic rate induced by SIL1 knockdown in HeLa cells

V Capone, E Clemente, E Restelli, A Di Campli… - … et Biophysica Acta (BBA …, 2018 - Elsevier
Loss-of-function mutations in the SIL1 gene are linked to Marinesco-Sjögren syndrome
(MSS), a rare multisystem disease of infancy characterized by cerebellar and skeletal …

Targeting the enhanced ER stress response in Marinesco-Sjögren syndrome

A Kashimada, S Hasegawa, T Isagai… - Journal of the …, 2018 - Elsevier
Abstract Background and objective Marinesco-Sjögren syndrome (MSS) is an autosomal
recessive infantile-onset disorder characterized by cataracts, cerebellar ataxia, and …

[HTML][HTML] In-depth phenotyping of lymphoblastoid cells suggests selective cellular vulnerability in Marinesco-Sjögren syndrome

L Kollipara, S Buchkremer, JAG Coraspe, D Hathazi… - Oncotarget, 2017 - ncbi.nlm.nih.gov
SIL1 is a ubiquitous protein of the Endoplasmic Reticulum (ER) acting as a co-chaperone for
the ER-resident chaperone, BiP. Recessive mutations of the corresponding gene lead to …

Sil1-mutant mice elucidate chaperone function in neurological disorders

S Buchkremer, JA González Coraspe… - Journal of …, 2016 - content.iospress.com
Chaperone dysfunction leading to the build-up of misfolded proteins could frequently be
linked to clinical manifestations also affecting the nervous system and the skeletal muscle. In …

Proteomic analysis of marinesco–sjogren syndrome fibroblasts indicates pro-survival metabolic adaptation to SIL1 loss

F Potenza, MC Cufaro, L Di Biase, V Panella… - International Journal of …, 2021 - mdpi.com
Marinesco–Sjogren syndrome (MSS) is a rare multisystem pediatric disorder, caused by loss-
of-function mutations in the gene encoding the endoplasmic reticulum cochaperone SIL1 …

[图书][B] The Role of BiP Co-chaperone SIL1 in Marinesco-Sjögren Syndrome Pathogenesis

VP Ichhaporia - 2018 - search.proquest.com
Marinesco-Sjögren syndrome (MSS) is a rare, autosomal recessive, multisystem disorder,
which is characterized by cerebellar ataxia, early-onset bilateral cataracts, and progressive …

Identification of cellular pathogenicity markers for SIL1 mutations linked to Marinesco-Sjögren syndrome

C Gatz, D Hathazi, U Münchberg, S Buchkremer… - Frontiers in …, 2019 - frontiersin.org
Background and objective: Recessive mutations in the SIL1 gene cause Marinesco-Sjögren
syndrome (MSS), a rare neuropediatric disorder. MSS-patients typically present with …